Headlines & Special Reports

Bristol-Myers Squibb Co (NYSE:BMY) Initiated with a Sell Rating

Stock Traders Daily has initiated coverage of Bristol-Myers Squibb Co (NYSE:BMY) with a sell rating.  Our rating is based on valuation that relates directly to earnings growth and our assessment suggests that the multiple currently being paid on shares of Bristol Myers far exceeds its growth rate making it expensive accordingly.

Read More

Improving Cost Basis using ProShares Ultra DJ-UBS Crude Oil (NYSEARCA:UCO) and Proshares Trust II (NYSEARCA:SCO)

The practice of improving cost basis is powerful but something that most individual investors don't recognize, and most institutional investors don't utilize. I have found this method of improving cost basis to be extremely powerful but it is restricted to the use of leveraged ETFs.

Read More

Eli Lilly and Co (NYSE:LLY) Started with a Sell at Stock Traders Daily

Extra items influencing EPS make shares of Eli Lilly and Co (NYSE:LLY) look very expensive to the naked eye, with a public PE of about 30x, but even after extracting those items the PE is still over 20x.  This is expensive too, and part of the rationale for the sell rating initiated by Stock Traders Daily.

Read More

International Paper Co (NYSE:IP) Started with Sell at Stock Traders Daily

International Paper Co (NYSE:IP) has been initiated with a sell rating at Stock Traders Daily.  Substantial declines in revenues aside, the macroeconomic landscape as that is defined by The Investment Rate does not bode well for stocks, not even ones that have already fallen.

Read More

American Express Company (NYSE:AXP) Initiated with a Sell Rating

Stock Traders Daily has initiated shares of American Express Company (NYSE:AXP) with a sell rating based on valuation.  Using an earnings growth model that compares PE multiples to earnings growth we cannot justify buying American Express and based on valuation believe shares will fall over the coming year.

Read More